Basal and Bolus Insulin Dose Changes after Switching Basal Insulin to Insulin Degludec in Patients with Type 1 DiabetesMellitus: A Pilot Study

Basal and Bolus Insulin Dose Changes after Switching Basal Insulin to Insulin Degludec in... Clin Drug Investig (2017) 37:845–852 DOI 10.1007/s40261-017-0541-0 ORIGINAL RESEARCH ARTICLE Basal and Bolus Insulin Dose Changes after Switching Basal Insulin to Insulin Degludec in Patients with Type 1 Diabetes Mellitus: A Pilot Study 1,3 1 1 1 • • • • Yoshiyuki Hamamoto Sachiko Honjo Kanta Fujimoto Shinsuke Tokumoto 1,2 1 1 • • Hiroki Ikeda Yoshiharu Wada Hiroyuki Koshiyama Published online: 17 June 2017 Springer International Publishing Switzerland 2017 Abstract switched from once-daily BI (21.7 ± 8.3 to 19.3 ± 8.8 Background and objectives Ultra-long-acting insulin U/day, p = 0.016) especially in the injection before degludec (DEG) has a longer duration of action and less breakfast and evening meal. Body weight and hypo- daily variability relative to other basal insulin (BI), and glycemia frequency was not significantly different. thus may benefit patients with type 1 diabetes mellitus Conclusion DEG improved glycemic control when swit- (T1DM). We examined the impact of switching BI to DEG ched from once-daily BI and maintained glycemic control on glycemic control and insulin dose in T1DM. when switched from twice-daily BI without increasing Methods T1DM patients (n = 22; six male; mean age: hypoglycemia. 64.5 ± 12.6 years) receiving basal-bolus insulin therapy were included. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Clinical Drug Investigation Springer Journals

Basal and Bolus Insulin Dose Changes after Switching Basal Insulin to Insulin Degludec in Patients with Type 1 DiabetesMellitus: A Pilot Study

Loading next page...
 
/lp/springer_journal/basal-and-bolus-insulin-dose-changes-after-switching-basal-insulin-to-m0bvUzunKk
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing Switzerland
Subject
Medicine & Public Health; Pharmacotherapy; Pharmacology/Toxicology; Internal Medicine
ISSN
1173-2563
eISSN
1179-1918
D.O.I.
10.1007/s40261-017-0541-0
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial